Dr. Zamarin on the Role of Vaccines in Cervical Cancer

Dmitriy Zamarin, MD, PhD
Published: Tuesday, Oct 03, 2017



Dmitriy Zamarin, MD, PhD, a medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the role of vaccines for patients with cervical cancer.

Cervical cancer presents itself as a good candidate for a vaccine-type of therapy because the majority of tumors are HPV-driven, explains Zamarin.

There are several vaccines that have been demonstrated to elicit specific immune responses. There is a vaccine from Inovio called VGX-3100 that was effective in the precancerous setting in patients with CIN 2/3, states Zamarin. This could then be effective in advanced settings.
 
SELECTED
LANGUAGE


Dmitriy Zamarin, MD, PhD, a medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the role of vaccines for patients with cervical cancer.

Cervical cancer presents itself as a good candidate for a vaccine-type of therapy because the majority of tumors are HPV-driven, explains Zamarin.

There are several vaccines that have been demonstrated to elicit specific immune responses. There is a vaccine from Inovio called VGX-3100 that was effective in the precancerous setting in patients with CIN 2/3, states Zamarin. This could then be effective in advanced settings.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x